OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (15)

  1. Yiyoung Kwon, Eun Sil Kim, Yon Ho Choe, Mi Jin Kim. Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children. Front. Pediatr. 2022;10
    https://doi.org/10.3389/fped.2022.846273
  2. Qinchen Xu, Maoxiao Feng, Yidan Ren, Xiaoyan Liu, Huiru Gao, Zigan Li, Xin Su, Qin Wang, Yunshan Wang. From NAFLD to HCC: Advances in noninvasive diagnosis. Biomedicine & Pharmacotherapy 2023;165:115028
    https://doi.org/10.1016/j.biopha.2023.115028
  3. Tyng‐Yuan Jang, Chung‐Feng Huang, Ming‐Lun Yeh, Ching‐I Huang, Chia‐Yen Dai, Pei‐Chien Tsai, Po‐Yau Hsu, Yi‐Ju Wei, Nai‐Jen Hou, Po‐Cheng Liang, Yi‐Hung Lin, Chih‐Wen Wang, Ming‐Yen Hsieh, Zu‐Yau Lin, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang. Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients. The Kaohsiung J of Med Scie 2022;38:261
    https://doi.org/10.1002/kjm2.12474
  4. Tsung-Ying Tsai, Pai-Feng Hsu, Cheng-Hsueh Wu, Shao-Sung Huang, Wan-Leong Chan, Shing-Jong Lin, Jaw-Wen Chen, Tse-Min Lu, Hsin-Bang Leu. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores. Nutrients 2022;14:3163
    https://doi.org/10.3390/nu14153163
  5. Siyao Gong, Xin Yu, Qian Li, Ming Chen, Shuguang Yu, Sha Yang. Evaluation of Mac-2 binding protein glycosylation isomer (M2BPGi) as a diagnostic marker for staging liver fibrosis: a meta-analysis. 2024;12:e17611
    https://doi.org/10.7717/peerj.17611
  6. Minjeong Nam, Mina Hur, Mikyoung Park, Hanah Kim. Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis. Diagnostics 2022;12:628
    https://doi.org/10.3390/diagnostics12030628
  7. Mina Hur, Mikyoung Park, Hee-Won Moon, Won Hyeok Choe, Chae Hoon Lee. Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer. Ann Lab Med 2022;42:249
    https://doi.org/10.3343/alm.2022.42.2.249
  8. Yoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, Kumiko Hosono, Yukiko Suama, Yukie Ohtakaki, Arihito Nauchi, Naoto Yasuda, Soh Mitsuta, Kouichi Miura, Takuma Yamamoto, Tatsunori Hosono, Akihiro Yoshida, Ippei Kawanishi, Hideaki Fukushima, Masao Kinoshita, Atsushi Umeda, Yuichi Kinoshita, Kana Fukami, Toshio Miyawaki, Hideki Fujii, Yuichi Yoshida, Miwa Kawanaka, Hideyuki Hyogo, Asahiro Morishita, Hideki Hayashi, Hiroshi Tobita, Kengo Tomita, Tadashi Ikegami, Hirokazu Takahashi, Masato Yoneda, Dae Won Jun, Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima. SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum. J Gastroenterol 2023;58:79
    https://doi.org/10.1007/s00535-022-01932-1
  9. Francesca Terracciani, Andrea Falcomatà, Paolo Gallo, Antonio Picardi, Umberto Vespasiani-Gentilucci. Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers. J Physiol Biochem 2023;79:851
    https://doi.org/10.1007/s13105-022-00934-0
  10. Ya. A. Krasner, M. F. Osipenko, N. V. Litvinova, E. A. Bikbulatova, S. I. Holin, V. V. Klimotov. Non-alcoholic fatty liver disease - a look at diagnostic prospects. jour 2021:62
    https://doi.org/10.31146/1682-8658-ecg-191-7-62-67
  11. Antonio Facciorusso, Daryl Ramai, Maria Cristina Conti Bellocchi, Laura Bernardoni, Erminia Manfrin, Nicola Muscatiello, Stefano Francesco Crinò. Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. Cancers 2021;13:3062
    https://doi.org/10.3390/cancers13123062
  12. Naoyuki Fujimori, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Taiki Okumura, Hiroyuki Kobayashi, Shun‐ichi Wakabayashi, Yuki Yamashita, Ayumi Sugiura, Jonathan Pham, Sai P. Pydi, Kenji Sano, Satoru Joshita, Takeji Umemura. 2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease. Hepatology Research 2022;52:352
    https://doi.org/10.1111/hepr.13745
  13. M. Elizabeth Sobhia, Sonia Kumari, Harish Kumar, Akshata Gandhe, Dhriti Kaushik, Harish Kumar, Jethender Jain, Ankita, Moyim Mallick, Bommana Pavani, Mridula Moudgil, Deepesh Patel. Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH. CTMC 2023;23:2027
    https://doi.org/10.2174/1568026623666230714113808
  14. Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front. Med. 2021;8
    https://doi.org/10.3389/fmed.2021.615978
  15. Yasuyuki Komiyama, Utaroh Motosugi, Shinya Maekawa, Leona Osawa, Natsuko Nakakuki, Hitomi Takada, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Shinichi Takano, Mitsuharu Fukasawa, Tatsuya Yamaguchi, Hiroshi Onishi, Meng Yin, Nobuyuki Enomoto. Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography. Hepatology Research 2023;53:208
    https://doi.org/10.1111/hepr.13858
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd